Opioids Flashcards

1
Q

Naturally occurring opioids

A

phenanthrenes (morphine and codeine)

benzylisoquinolines (papaverine)

Thebaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Semisynthetic opioids

A

Heroin

Dihydromorphone, morphinone

Thebaine derivatives (e.g., etorphine, buprenorphine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Synthetic opioids

A

Morphinan derivatives (e.g., levorphanol, butorphanol)

Diphenylpropylamine derivatives (e.g., methadone)

Benzomorphan derivatives (e.g., pentazocine)

Phenylpiperidine derivatives (e.g., meperidine, fentanyl, sufentanil,
alfentanil, remifentanil)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Morphine binds to the μ-opioid receptor protein to form an active complex with signaling proteins, including …

The … signaling pathway is thought to mediate analgesic action of morphine, whereas … signaling results in unwanted side effects including euphoria, which can lead to addiction, respiratory depression, and gastrointestinal effects

A

Gi/o and β-arrestin

Gi/o

β-arrestin

OBS.: TRV130, a “G protein-biased” μ-opioid ligand with G-protein–coupling efficacy similar to that of morphine, but markedly reduced receptor phosphorylation, recruitment of β-arrestin 2, and internalization, was tested in a randomized, double-blind, placebo-controlled crossover study in healthy volunteers. TRV130 produced greater analgesia than morphine, but less respiratory depression and
less severe nausea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mechanism of opioid analgesia in the brain

A

The analgesic effects of opioids arise from their ability to inhibit directly the ascending transmission of nociceptive information from the spinal cord dorsal horn and to activate pain control circuits that descend from the midbrain, through the rostral ventromedial medulla (RVM), to the spinal cord dorsal horn.

Petrovic and colleagues used an experimental pain model and positron emission tomography (PET) to study mechanisms of action of the short-acting μ-opioid agonist remifentanil and found drug-induced activation of the rostral anterior cingulate cortex, insula, orbitofrontal cortex, and brainstem areas. The activated brainstem regions overlapped with brain areas that have been implicated in pain modulation, such as the periaqueductal gray (PAG).

The μ receptor produces analgesia within descending pain control circuits, at least in part, by the removal of γ-aminobutyric acidergic inhibition of RVM-projecting neurons in the PAG and spinally projecting neurons in the RVM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mechanism of opioid analgesia in the spinal cord

A

Local spinal mechanisms, in addition to descending inhibition, underlie the analgesic action of opioids.
In the spinal cord, opioids act at synapses either presynaptically or postsynaptically.

Opioid receptors are abundantly expressed in the substantia gelatinosa, where glutamate and substance P release from the primary sensory neuron is inhibited by opioids.

Histamine receptors are known to participate in spinal cord nociceptive transmission, and previous studies have suggested that histaminergic receptors are also involved in the analgesic effects of morphine. An H1 antagonist and H3 agonist were found to potentiate the analgesic and antiedematogenic effects of morphine, suggesting that histaminergic and opioid spinal systems may be explored for means of improving analgesia, as well as peripheral antiinflammatory effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Methadone is clinically used as a racemic mixture of the l and d isomers. The opioid-like activity of the racemate seems to be almost entirely the result of …, whereas … acts as an …

A

l-methadone

d-methadone

NMDA antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The serotonin type 3A (5-HT3A) receptor, which is directly and indirectly linked to … , is competitively inhibited by morphine and hydromorphone, as well as naloxone; however, fentanyl-like opioids did not significantly affect activity of the 5-HT3A receptor

A

gastrointestinal motility, visceral pain, nausea, and vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The mechanism for tramadol analgesia is complex and appears
to be composed of two actions that include …

A

reuptake inhibition of the noradrenergic serotonergic system and activation of the μ-opioid receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe a possible neurochemical basis of opioid-induced change in consciousness

A

Cortical acetylcholine originates in the basal forebrain and is essential for maintaining normal cognition and arousal. Injection of morphine to the substantia innominata or intravenous morphine administration significantly decreased acetylcholine release within the prefrontal cortex in the rat, and this effect may be the neurochemical basis of opioid-induced change in consciousness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Many hypotheses have been advanced to explain the etiology of opioid-induced hallucinations. One common feature of these hypotheses involves opioid-induced …
Overactivation of the … is thought to result in auditory and visual hallucinations

A

dopamine dysregulation

dopaminergic pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Opioids effectes on the electroencephalography

A

Small doses of fentanyl (2-5 μg/kg) produce minimal EEG changes, whereas higher doses (30-70 μg/kg) result in high-voltage slow (δ) waves suggesting a state consistent with anesthesia.

In a study, At 1 minute with 37.5 μg of sufentanil, the EEG showed loss of β activity and the presence of primarily α waves (8-13 Hz).
At 3.5 minutes and 65.6 μg of sufentanil, the EEG consisted of mixed θ (4-7 Hz) and δ (<4 Hz) waves, and at 4.0 min and 75 μg of sufentanil, it consisted of δ waves of high amplitude

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do opioids affect evoked responses?

A
  • Opioids do not appreciably alter sensory-evoked potentials elicited at the posterior tibial or median nerve;
  • Remifentanil produced dose-dependent reduction in auditory-evoked potentials, but it was also reported that remifentanil infusion (target plasma concentrations of 1, 2, and 3 ng/mL) did not affect evoked potential amplitudes and latencies;
  • In healthy human volunteers receiving 3 μg/kg fentanyl, amplitude and latency of motor-evoked responses to transcranial stimulation were not significantly affected;
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do opioids affect the CNS perfusion?

A

Opioids, in general, do not significantly effect measures of CBF.

Opioids are generally thought to affect ICP minimally under
conditions of controlled ventilation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain the muscle rigidity and the difficult ventilation tha may occur after opioid administration

A

Opioid-induced rigidity is characterized by increased muscle tone that sometimes progresses to severe stiffness and associated clinical challenges.

Clinically significant opioid-induced rigidity usually begins just as, or after, a patient loses consciousness. Mild manifestations of rigidity, such as hoarseness, can occur in conscious patients.

Vocal cord closure is primarily responsible for the difficult ventilation with bag and mask that follows the administration of opioids

The precise mechanism by which opioids cause muscle
rigidity is not clearly understood.
The nucleus raphe pontis within the reticular formation and the caudate nucleus within the basal ganglia have been implicated mechanistically.
Pharmacologic investigation using selective agonists and antagonists suggests that systemic opioid-induced muscle rigidity is primarily caused by the activation of central μ-receptors, whereas supraspinal δ1 and κ1 receptors may attenuate this effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Opiods do not produce EEG seizure activity.

T or F

A

F

Focal neuroexcitation on the EEG (e.g., sharp and spike wave activity) occasionally occurs in humans after large doses of fentanyl, sufentanil, and alfentanil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How do opioids affect the pupile size?

A

Morphine and most μ− and κ−agonists cause constriction of the pupil by an excitatory action on the parasympathetic nerve innervating the pupil.

Light induces excitation of the Edinger-Westphal nucleus leading to pupillary constriction, which is inhibited by hypercarbia, hypoxia, and nociception. Opioids release the effect of inhibitory neurons on the
Edinger-Westphal nucleus, resulting in papillary constriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Opioid-based anesthesia probably reduces thermoregulatory thresholds to a degree similar to that of the potent inhaled anesthetics. However, … is unique among opioids in its ability to effectively terminate or attenuate shivering. The antishivering effect of … is primarily related to a reduction in the shivering threshold

A

meperidine

meperidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

A quantitative systematic review of randomized controlled trials found that meperidine … mg and … 35 to 220 mg were more effective than control for parenteral pharmacologic interventions for the prevention of postoperative shivering

A

12.5 to 35

tramadol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Name an opioid associated with an increase in postanesthetic shivering. Explain the probable mechanism.

A

Remifentanil is associated with an increased incidence of postanesthetic shivering, which is not related with intraoperative hypothermia.
The higher incidence of postanesthetic shivering with higher doses of remifentanil probably reflects acute opioid tolerance and stimulation of the NMDA receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Opioids activating the … receptor cause dose-dependent depression of respiration, primarily through a direct action on …

A

μ

brainstem respiratory centers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

High doses of opioids usually eliminate spontaneous respirations without necessarily producing unconsciousness. Patients receiving high doses of opioids may still be responsive to verbal command and
often breathe when they are directed to do so

T or F

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Factors Increasing the Magnitude and/or Duration of Opioid-Induced
Respiratory Depression

A
  • High dose
  • Sleep
  • Old age
  • Central nervous system depressant (Inhaled anesthetics, alcohol, barbiturates, benzodiazepines)
  • Renal insufficiency
  • Hyperventilation, hypocapnia
  • Respiratory acidosis
  • Decreased clearance
  • Reduction of hepatic blood flow
  • Secondary peaks in plasma opioid levels
  • Reuptake of opioids from muscle, lung, fat, and intestine
  • Pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How do opioids modulate the autonomic nervous system? How does this influence the cardiovascular system?

A

Most opioids reduce sympathetic and enhance vagal and parasympathetic tone. Patients who are volume depleted, or individuals depending on high sympathetic
tone or exogenous catecholamines to maintain cardiovascular function, are predisposed to hypotension after opioid administration.
The predominant and usual effect of opioids on heart rate is bradycardia resulting from stimulation of the central vagal nucleus. Blockade of sympathetic actions may
also play a role in opioid-induced bradycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Which opioid is most associated with tachycardia?

A

Meperidine, in contrast to other opioids, rarely results in bradycardia, but it can cause tachycardia. Tachycardia after meperidine may be related to its structural similarity to atropine, to normeperidine, its principal metabolite, or to early manifestations
of its toxic CNS effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

The oculocardiac reflex, which is caused by traction of extraocular muscles during strabismus surgery, was significantly … by fentanyl, sufentanil, and remifentanil

A

augmented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How do opioids affect Myocardial Ischemia?

A

Opioids can mimic ischemic preconditioning. Opioid receptor stimulation results in a reduction in infarct size similar to that produced by ischemic preconditioning. Although the preconditioning effect of opioids is mediated mainly by the cardiac κ- and δ-opioid receptors, part of the protective effect of remifentanil may be produced by μ-agonist activity outside the heart.

Whether the experimental results showing protective effects of opioid against myocardial ischemia will translate into reductions in morbidity and mortality in patients with coronary artery disease has yet to be established by clinical trials. Clinically, high doses of opioids can maintain myocardial perfusion and the O2
supply-demand ratio as well or better than can inhalation based techniques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

It is well known that morphine causes histamine release and sympathoadrenal activation.

… are examples of other opioids that can induce mast cell activation with the release of histamine, probably by a mechanism other than the μ-opioid receptors.

Unlike morphine, the opioids … do not produce increases in plasma histamine,
subsequently hypotension is less frequent with their administration

A

Codeine and meperidine

fentanyl, alfentanil, sufentanil, and remifentanil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

In humans endocrine system, opioids generally increase … , and decrease …

The effects of opioids on … are conflicting.

The primary endocrine disorder that results from opioid misuse is …

A

growth hormone, thyroid stimulating hormone, and prolactin

luteinizing hormone, testosterone, estradiol, and oxytocin

arginine vasopressin and ACTH

hypogonadism, particularly in males

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

The main components of the neuroendocrine stress response are …
and …

Morphine modifies hormonal responses to surgical trauma in a dose-related fashion through …

A

the corticotropin-releasing hormone brain centers (e.g., paraventricular hypothalamic nucleus)

the locus ceruleus-norepinephrine/autonomic nervous system

blockade of ACTH release, suppression of surgically induced increases
in plasma cortisol, and attenuation of the pituitary-adrenal response to surgical stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Opioids effects in the urinary tract

A

The mechanism by which opioids cause urinary retention is incompletely understood. Opioid effects on the lower urinary tract include disturbances of micturition characterized by urinary retention, especially after intrathecal opioid administration. Intrathecal administration of morphine and sufentanil caused dose-dependent suppression of detrusor contractility and decreased sensation of urge. Mean times to recovery of normal lower urinary tract function were 5 and 8 hours after 10 or 30 μg sufentanil and 14 and 20 hours after 0.1 or 0.3 mg morphine, respectively.

31
Q

Effects of opioids on the gastrointestinal tract

A
  • Decreased gastric motility and emptying: Decreased appetite; increased gastroesophageal reflux
  • Decreased pyloric tone: Nausea and vomiting
  • Decreased enzymatic secretion: Delayed digestion; hard, dry stools
  • Inhibition of small and large bowel propulsion: Delayed absorption of medication; straining; incomplete evacuation; bloating; abdominal distension; constipation
  • Increased fluid and electrolyte absorption: Hard, dry stools
  • Increased nonpropulsive segmental contractions: Spasms; abdominal cramps; pain
  • Increased anal sphincter tone: Incomplete evacuation
32
Q

…, a quaternary naloxone derivative that does not cross the blood-brain barrier, can attenuate morphine-induced delays in gastric emptying, suggesting that a peripheral mechanism is involved in the opioid effect on gastrointestinal tract

A

Methylnaltrexone

33
Q

Increases in biliary pressure caused by opioids are, with the exception of …, reversible with naloxone

A

meperidine

34
Q

Opioids stimulate the chemoreceptor trigger zone in the area postrema of the medulla possibly through …-receptors, leading to nausea and vomiting

A

δ

35
Q

Opioids effects on adaptive immunity

A

↓ Splenic and thymic weight (rodents)
↓ T cell viability and proliferative response
↓ T-helper cell function
↓ CD4/CD8 population in vivo
↓ IL1β, IL-2, TNF-α, and IFN-γ (mouse splenocytes)
↓ Th1/Th2 ratio of T-helper cell population (PBMCs)
↓ NK cell activity
↓ Primary antibody response (B cells)
↓ B cells mitogenic response to bacterial LPS
↓ Macrophage activity
↓ TGF-β1 and IL-10 (antiinflammatory cytokines)
↑ T cell apoptosis (NF-κβ and AP-1/NFAT pathways) Inhibition of CD3/28 mAb induced IL-2 transcripts

36
Q

Opioids effects on innate immunity

A

↓ Number of macrophages available to fight infections
↓ Leucocyte migration
↓ Peritoneal macrophages phagocytosis
↓ Respiratory burst activity and chemotaxis
- Inhibition of Fc γ receptor mediated phagocytosis
↓ Superoxide production from neutrophils and macrophages
- Alteration of IL-8 induced neutrophil chemotaxis
↓ Neutrophil cytokines involved in wound healing
↑ Apoptosis of macrophages impairing host defense barrier
↓ Leucocytes endothelial adhesion (intracellular adhesion molecules expression)

37
Q

The central immune modulatory effect of opioids is mediated by … receptors

A

μ-opioid

38
Q

Opioids are weak acids. When dissolved in solution, they are dissociated into protonated and free-acid fractions, with the relative proportions depending on the pH and pKa. The free-acid fraction is more lipid-soluble than the protonated fraction. High lipid solubility difficult opioid transport into the biophase or site of action. Therefore, highly lipid-soluble opioids have a more slow onset of action. However, because the opioid receptor recognizes an opioid molecule in the protonated form, the intensity of opioid effects is closely related to the ionized concentration of drug in the biophase

T or F

A

F

Opioids are weak bases. When dissolved in solution, they are dissociated into protonated and free-base fractions, with the relative proportions depending on the pH and pKa. The free-base fraction is more lipid-soluble than the protonated fraction. High lipid solubility facilitates opioid transport into the biophase or site of action. Therefore, highly lipid-soluble opioids have a more rapid onset of action. However, because the opioid receptor recognizes an opioid molecule in the protonated form, the intensity of opi- oid effects is closely related to the ionized concentration of drug in the biophase

39
Q

Morphine metabolism

A

Morphine is principally metabolized by conjugation in the liver, but the kidney plays a key role in the extrahepatic metabolism of morphine. M3G is the major metabolite of morphine, but does not bind to opioid receptors and possesses little or no analgesic activity. M3G may actually antagonize morphine, and this effect may contribute to both variability in response and resistance to morphine analgesic therapy. M3G was reported to produce seizures in animals and cause allodynia in children. M6G accounts for nearly 10% of morphine metabolite and is a more potent μ-receptor agonist than morphine with a similar duration of action. It was reported that M6G contributes substantially to morphine’s analgesic effects even in patients with normal renal function. A recent study reported that based on area under the concentration–time curve there was a major contribution of M6G to the overall analgesic effect; the mean contributions being estimated as 96.6%, 85.6%, 85.4%, and 91.3% after oral, subcutaneous, intravenous, and rectal administration of morphine, respectively. In patients with renal insufficiency, 97.6% of the analgesic effect is caused by M6G when morphine is given orally. Especially in patients with renal dysfunction, the accumulation of M6G can lead to an increased incidence of adverse effects, including respiratory depression.

40
Q

Why remifentanil is not approved to be used intrathecally?

A

The remifentanil free base is formulated with glycine. Because glycine has been shown to act as an inhibitory neurotransmitter that causes a reversible motor weakness when injected intrathecally in rodents, remifentanil is not approved for spinal or epidural use

41
Q

Pseudocholinesterase deficiency greatly increase the remifentanil duration of action

T or F

A

F

Remifentanil is not a good substrate for pseudocholinesterase and, therefore, is not influenced by pseudocholinesterase deficiency.

Remifentanil’s ester structure renders it susceptible to hydrolysis by blood- and tissue-nonspecific esterases

42
Q

Many opioid pharmacokinetic parameters, especially clearance, appear to be more closely related to total body weight

T or F

A

F

Many opioid pharmacokinetic parameters, especially clear- ance, appear to be more closely related to lean body mass

43
Q

Renal failure has implications of major clinical importance with respect to morphine, hydromorphone, and meperidine. For the fentanyl congeners, the clinical importance of renal failure is less marked

T or F

A

T

44
Q

Why does renal failure make meperidine use dangerous?

A

Because normeperidine, the main metabolite of meperidine with analgesic and CNS excitatory effect, is subject to renal excretion, the potential CNS toxicity secondary to normeperidine accumulation is especially a concern in patients in renal failure.

45
Q

It was demonstrated that pH changes influence the protein binding of fentanyl, sufentanil, and alfentanil, resulting in an increase in protein binding with … and a decrease with …

These effects are greater for fentanyl than sufentanil and sufentanil than alfentanil

A

alkalosis

acidosis

46
Q

Although … is involved in the metabolism of many of the opioids, it is the role of the highly polymorphic … that is of greater clinical interest with respect to the weaker opioids (codeine, dihydrocodeine, oxycodone, hydrocodone, and tramadol), because of the formation of their more potent hydroxyl metabolites (morphine, dihydromorphine, oxymorphone, and hydromorphone), which have about a 30-fold higher affinity for the μ-receptor.

A

CYP3A4

CYP2D6

47
Q

Describe the plasma concentration of remifentanil for major surgery, minor surgery, spontaneous ventilation and analgesia

A

Major surgery: 2-4 ng/ml

Minor surgery: 1-3 ng/ml

Spontaneous ventilation: 0.3-0.6 ng/ml

Analgesia: 0.2-0.4 ng/ml

48
Q

Maintenance of anesthesia can be achieved with low concentrations of potent inhaled anesthetics, and additional fentanyl (intermittent boluses of … μg every … or a constant infusion of … μg/kg/h).

A

25-50

15-30 minutes

0.5-5.0

49
Q

Alfentanil (… μg/kg IV), followed by small titrated sleep doses of any sedative-hyponic (e.g., 50-100 mg sodium thiopental), is usually successful in preventing significant hemodynamic stimulation from laryngoscopy and intubation. The optimum dose of alfentanil, coadministered with 2.5 mg/kg propofol, when inserting a classic laryngeal mask airway was … μg/kg. Further opioid supplementation can be achieved with an alfentanil infusion (… μg/ kg/min) or intermittent boluses of alfentanil (…μg/kg) for shorter procedures

A

25-50

10

0.5-2.0

5-10

50
Q

In combination with propofol for induction of anesthesia in children, bolus administration of sufentanil … μg/kg can completely abolish the cardiovascular response to tracheal intubation. In healthy normotensive adult patients, a bolus sufentanil … μg/kg followed by a continuous infusion at … μg/kg/min for at least 5 minutes proved to be effective for blunting the cardiovascular response to intubation. Maintenance of anesthesia can be achieved with sufentanil (intermittent boluses, … μg/kg, or constant infusion, …)

A

0.3

0.1

0.08

0.1-0.25

0.5-1.5 μg/ kg/h

51
Q

Remifentanil infusion rates of … should permit the return of spontaneous ventilation and responsiveness with maintenance of analgesia

A

0.1 ± 0.05 μg/kg/min

52
Q

Approximate Opioid Loading (Bolus) Doses, Maintenance Infusion Rates, and Additional Maintenance Doses for Total Intravenous Anesthesia

A

Loading Dose
- Alfentanil: 25-100 μg/kg
- Sufentanil 0.25-2 μg/kg
- Fentanyl: 4-20 μg/kg
- Remifentanil: 1-2 μg/kg

Maintenance Infusion Rate
- Alfentanil: 0.5-2 μg/kg/min
- Sufentanil: 0.5-1.5 μg/kg/h
- Fentanyl: 2-10 μg/kg/h
- Remifentanil: 0.1-1.0 μg/kg/min

Additional Boluses
- Alfentanil: 5-10 μg/kg
- Sufentanil: 5-10 μg/kg
- Fentanyl: 25-100 μg
- Remifentanil: 0.1-1.0 μg/kg

53
Q

Besides the agonist of opioids receptor, which are the other mechanism of action of methadone?

A

By virtue of one of methadone’s isomers, it also exerts an inhibitory effect on NMDA receptors, Furthermore, methadone inhibits the reuptake of serotonin and norepinephrine, which may play a role in antinociception and mood elevation

54
Q

Methadone (IV) has an equivalent potency but longer duration of action than morphine. The plasma half-life of methadone is very long and variable (…). Despite this property, many patients require dosing every … to maintain analgesic effects. Its major clinical applications are in the prevention of opioid withdrawal symptoms and in the treatment of chronic pain

A

13-100 hours

4 to 8 hours

55
Q

Tramadol is a prodrug that is metabolized by … to its more potent opioid analgesic metabolites, particularly the …

A

CYP2D6 and CYP3A4

O-demethylation product M1

56
Q

The action of tramadol to induce analgesia represents the combination of two predominant mechanisms: …

A

reuptake inhibition of the noradrenergic serotonergic system and activation of the μ-opioid receptor and to a lesser extent the δ- and κ-opioid receptors

57
Q

Tramadol has dose- and time-dependent bactericidal activity against …, as well as antibacterial activity against …

A

Escherichia coli and Staphylococcus epidermidis

Staphylococcus aureus and Pseudomonas aeruginosa

58
Q

Coadministration of tramadol with proserotonergic medications can result in a hyperserotonergic state, serotonin syndrome, which can be subacute or chronic, and range from mild to severe. In mild cases, patients are … . In severe cases, … have been reported.

Serotonergic medications that can interact with tramadol include selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, …

A

afebrile and may report symptoms of diarrhea, tremor, tachycardia, shivering, diaphoresis, or mydriasis

neuromuscular hyperactivity, autonomic hyperactivity, altered mental state, gastrointestinal symptoms, and even death

triptans (e.g., sumatriptan), antipsychotics, anticonvulsants, antiparkinsonian agents, cough and cold medications containing dextromethorphan, herbal products containing St. John’s wort, and medications that inhibit the metabolism of serotonin, such as monoamine oxidase inhibitors

59
Q

Buprenorphine is a partial agonist at the …-receptor and an antagonist at the …-receptor

A

μ

κ

60
Q

Agonist-antagonist opioids are less prone (but not immune) to abuse because they …

A

have analgesic ceiling effects, cause less euphoria, and are associated with less drug-seeking behavior and physical dependence

61
Q

Analgesia produced by pentazocine (an opioid agonist-antagonist) is primarily related to …-receptor stimulation.

Pentazocine has been shown to be an effective treatment for … after cesarean delivery under spinal anesthesia with opioids

Pentazocine has limited application, because it is associated with a high incidence of …, it provides limited analgesia, it partially antagonizes other opioids, and it can produce undesirable cardiovascular and psychotomimetic effects.

A

κ

pruritus

PONV

62
Q

Acute biliary spasm can occur after butorphanol (an opioid agonist-antagonist), but increases in biliary pressure are less than after equipotent doses of fentanyl or morphine

T or F

A

T

63
Q

Onset of action of buprenorphine is slow, its peak effect may not occur until …, and duration of effect is prolonged (…)

A

3 hours

<10 hours

64
Q

Nalbuphine is an agonist-antagonist opioid that is structurally related to oxymorphone and naloxone, and binds to μ-receptors as well as to κ- and δ-receptors. Nalbuphine acts as an antagonist at the …-receptor and an agonist at the …-receptor.

Onset of effects is rapid (…), and duration is long (…) because of a long plasma elimination half-life (…).

A

μ

κ

5-10 minutes

3-6 hours

5 hours

65
Q

Clinically, opioid antagonists are used to restore spontaneous ventilation in patients who breathe inadequately after opioid overdoses or opioid anesthesia. In addition, opioid antagonists can reduce or reverse opioid-induced … associated with numerous therapies employing opioids, such as neuraxial analgesic techniques

A

nausea and vomiting, pruritus, urinary retention, rigidity, and biliary spasm

66
Q

Initial naloxone dose recommendations ranged from …

Onset of action of IV naloxone is rapid (…), and half-life and duration of effect are short, approximately …

A

0.4 to 0.8 mg

1-2 minutes

30 to 60 minutes

67
Q

Effects of naloxone administration on the cardiovascular system when it is used for reversal of opioids intoxication

A

Several mechanisms produce increases in arterial blood pressure, heart rate, and other significant hemodynamic alterations after naloxone reversal of opioids. These include pain, rapid awakening, and sympathetic activation not necessarily due to pain. When patients receiving naloxone for opioid agonist reversal are hypothermic due to intraoperative heat loss, O2 consumption and minute ventilation can increase two to threefold. Such metabolic demands also stress the cardiovascular system, increasing cardiac output. In addition, greater degrees of hypercapnia at the time of opioid antagonism will result in greater degrees of cardiovascular stimulation because of associated sympathetic stimulation

68
Q

Low-dose naloxone not only has been shown to block the development of acute opioid tolerance but also to ameliorate undesired opioid-induced side effects. Naloxone infusion … prevented the acute opioid tolerance induced by a large dose of remifentanil at 0.30 μg/kg/min, provided a quicker recovery of bowel function, and reduced the length of hospital stay after open colorectal surgery

A

0.25 μg/kg/h

69
Q

Naltrexone is a …-opioid receptor antagonist. It is longer acting than naloxone (plasma half-life of … vs. 0.5-1.5 hours), and it is active when taken orally

A

μ-, δ-, and κ

8-12 hours

70
Q

A double-blind, placebo-controlled study for patients undergoing cesarean section indicated that naltrexone (… mg) was an effective oral prophylactic against the … associated with intrathecal morphine, but was associated with shorter duration of analgesia

A

6

pruritus and vomiting

71
Q

… is the first quaternary ammonium opioid receptor antagonist that does not cross the blood-brain barrier.

It can reverse adverse effects of opioid medications mediated by peripheral opioid receptors, while the opioid effects mediated by opioid receptors in the central nervous system, such as analgesia, are not affected

A

Methylnaltrexone

72
Q

Methylnaltrexone has been shown to be effective for management of opioid-induced constipation. It was reported that subcutaneous methylnaltrexone (…) rapidly induced laxation in patients who had received opioids for 2 or more weeks and who had received stable doses of opioids and laxatives for 3 or more days without relief of opioid-induced constipation

A

0.15 mg/ kg

73
Q

Methylnaltrexone is restricted by the need for subcutaneous administration and is approved only for treatment of opioid-induced constipation in patients with advanced medical illness.
…, an oral peripherally acting μ-opioid antagonist, is a pegylated derivative of naloxone. Pegylation confers substrate properties for P-glycoprotein transporter and thus limits the ability of … to …

A double-blind study in outpatients with noncancer pain and opioid-induced constipation demonstrated that a daily dose of 12.5 mg or 25 mg … improved bowel movement, as compared with placebo, without changing pain scores and daily opioid dose

A

Naloxegol

naloxegol

cross the blood–brain barrier

naloxegol

74
Q

The phenylpiperidine series opioids, including …, appear to be weak serotonin reuptake inhibitors and have all been involved in serotonin toxicity reactions with MAOIs, whereas morphine, codeine, oxycodone, and buprenorphine are known not to be serotonin reuptake inhibitors, and do not precipitate serotonin toxicity with MAOIs

A

meperidine, tramadol, and methadone

75
Q

Gabapentinoids, such as gabapentin and pregabalin, structural analogs of …, bind to the …, and produce antihyperalgesic effects in neuropathic and other painful conditions. It was suggested that both pharmacodynamic and pharmacokinetic interaction between morphine and gabapentin leads to increased analgesic effects

A

γ-aminobutyric acid

α2δ subunit of spinal voltage-gated calcium channel